Global castrate resistant prostate cancer market statistics, by therapy, 2016-2027 (USD Million)
Global castrate-resistant prostate cancer market by therapy size was valued at 6,562.1 USD million in 2017 and is estimated to grow at a compound annual growth rate (CAGR) of 7.9% from 2018 to 2027.